$9.55
+0.73 (+8.28%)
Open$8.78
Previous Close$8.82
Day High$9.62
Day Low$8.78
52W High$14.21
52W Low$2.30
Volume—
Avg Volume27.4K
Market Cap92.62M
P/E Ratio—
EPS$-21.31
SectorPharmaceuticals
Analyst Ratings
Strong Buy
9 analysts
Price Target
+321.2% upside
Current
$9.55
$9.55
Target
$40.22
$40.22
$30.63
$40.22 avg
$46.08
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 9.05M | 8.81M | 7.55M |
| Net Income | 1.50M | 1.95M | 1.65M |
| Profit Margin | 16.6% | 22.2% | 21.9% |
| EBITDA | 2.36M | 2.47M | 1.95M |
| Free Cash Flow | 1.28M | 1.29M | 705.7K |
| Rev Growth | -8.9% | +8.5% | +16.9% |
| Debt/Equity | 0.33 | 0.32 | 0.30 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $948.45 | -2.72% | 36.1 | 913.24B |
| JNJ | Johnson & Johnson | $221.32 | -0.53% | 26.1 | 548.94B |
| MRK | Merck & Co. Inc. | $111.38 | -0.82% | 31.3 | 279.42B |
| PFE | Pfizer Inc. | $25.68 | -3.02% | 19.3 | 150.09B |
| BMY | Bristol-Myers Squibb Co | $56.16 | -0.16% | 17.0 | 120.08B |
| ZTS | Zoetis Inc | $82.83 | -5.13% | 21.5 | 57.37B |